FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3039348232> ?p ?o ?g. }

• W3039348232 endingPage "107328" @default.
• W3039348232 startingPage "107328" @default.
• W3039348232 abstract "Glycogen Synthase Kinase 3 (GSK-3) is a member of cellular kinase with various functions, such as glucose regulation, cellular differentiation, neuronal function and cell apoptosis. It has been proved as an important therapeutic target in type 2 diabetes mellitus and Alzheimer's disease. To better understand their structure–activity relationships and mechanism of action, an integrated computational study, including three dimensional quantitative structure-activity relationship (3D-QSAR), molecular docking, and molecular dynamics (MD), was performed on 79 (5-Imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine GSK-3 inhibitors. In this paper, we constructed 3D-QSAR using comparative molecular field analysis (CoMFA) and comparative molecular similarity index analysis (CoMSIA) method. The results showed that the CoMFA model (q 2 = 0.743, r2 = 0.980) and the CoMSIA model (q2 = 0.813, r2 = 0.976) had stable and reliable predictive ability. The electrostatic and H-bond donor fields play important roles in the models. The contour maps of the model visually showed the relationship between the activity of compounds and their three-dimensional structure. Molecular docking was used to identify the key amino acid residues at the active site of GSK-3 and explore its binding mode with ligands. Based on 3D-QSAR models, contour maps and the binding feature between GSK-3 and inhibitor, we designed 10 novel compounds with good potential activity and ADME/T profile. Molecular dynamics simulation results validated that Ile62, Val70 and Lys85 located in the active site play a key role for GSK-3 complexed with inhibitors. These results might provide important information for designing GSK-3 inhibitors with high activity." @default.
• W3039348232 created "2020-07-10" @default.
• W3039348232 creator A5019691939 @default.
• W3039348232 creator A5028922128 @default.
• W3039348232 creator A5035742417 @default.
• W3039348232 creator A5043934458 @default.
• W3039348232 creator A5062509175 @default.
• W3039348232 creator A5073533587 @default.
• W3039348232 creator A5084655226 @default.
• W3039348232 creator A5086685216 @default.
• W3039348232 date "2020-10-01" @default.
• W3039348232 modified "2023-10-14" @default.
• W3039348232 title "In silico design novel (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine derivatives as inhibitors for glycogen synthase kinase 3 based on 3D-QSAR, molecular docking and molecular dynamics simulation" @default.
• W3039348232 cites W1971723047 @default.
• W3039348232 cites W1975580333 @default.
• W3039348232 cites W1980933072 @default.
• W3039348232 cites W1994941561 @default.
• W3039348232 cites W1995862772 @default.
• W3039348232 cites W2003721045 @default.
• W3039348232 cites W2004822259 @default.
• W3039348232 cites W2008517160 @default.
• W3039348232 cites W2014858249 @default.
• W3039348232 cites W2018137081 @default.
• W3039348232 cites W2022913744 @default.
• W3039348232 cites W2035687084 @default.
• W3039348232 cites W2043666236 @default.
• W3039348232 cites W2045290587 @default.
• W3039348232 cites W2047427096 @default.
• W3039348232 cites W2047730466 @default.
• W3039348232 cites W2049875806 @default.
• W3039348232 cites W2054042932 @default.
• W3039348232 cites W2054796530 @default.
• W3039348232 cites W2067174909 @default.
• W3039348232 cites W2069659771 @default.
• W3039348232 cites W2073503722 @default.
• W3039348232 cites W2075369230 @default.
• W3039348232 cites W2096286606 @default.
• W3039348232 cites W2101510325 @default.
• W3039348232 cites W2105103540 @default.
• W3039348232 cites W2106140689 @default.
• W3039348232 cites W2134544924 @default.
• W3039348232 cites W2153399820 @default.
• W3039348232 cites W2156879354 @default.
• W3039348232 cites W2161239029 @default.
• W3039348232 cites W2290621935 @default.
• W3039348232 cites W2292665223 @default.
• W3039348232 cites W2297880637 @default.
• W3039348232 cites W2313116527 @default.
• W3039348232 cites W2335788856 @default.
• W3039348232 cites W2399856928 @default.
• W3039348232 cites W2566589587 @default.
• W3039348232 cites W2764187452 @default.
• W3039348232 cites W2910315286 @default.
• W3039348232 cites W2916983011 @default.
• W3039348232 cites W2934220040 @default.
• W3039348232 cites W2943838845 @default.
• W3039348232 cites W901067443 @default.
• W3039348232 doi "https://doi.org/10.1016/j.compbiolchem.2020.107328" @default.
• W3039348232 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32688011" @default.
• W3039348232 hasPublicationYear "2020" @default.
• W3039348232 type Work @default.
• W3039348232 sameAs 3039348232 @default.
• W3039348232 citedByCount "6" @default.
• W3039348232 countsByYear W30393482322021 @default.
• W3039348232 countsByYear W30393482322022 @default.
• W3039348232 countsByYear W30393482322023 @default.
• W3039348232 crossrefType "journal-article" @default.
• W3039348232 hasAuthorship W3039348232A5019691939 @default.
• W3039348232 hasAuthorship W3039348232A5028922128 @default.
• W3039348232 hasAuthorship W3039348232A5035742417 @default.
• W3039348232 hasAuthorship W3039348232A5043934458 @default.
• W3039348232 hasAuthorship W3039348232A5062509175 @default.
• W3039348232 hasAuthorship W3039348232A5073533587 @default.
• W3039348232 hasAuthorship W3039348232A5084655226 @default.
• W3039348232 hasAuthorship W3039348232A5086685216 @default.
• W3039348232 hasConcept C104317684 @default.
• W3039348232 hasConcept C139489369 @default.
• W3039348232 hasConcept C147597530 @default.
• W3039348232 hasConcept C159110408 @default.
• W3039348232 hasConcept C164126121 @default.
• W3039348232 hasConcept C178910836 @default.
• W3039348232 hasConcept C181199279 @default.
• W3039348232 hasConcept C182996813 @default.
• W3039348232 hasConcept C184235292 @default.
• W3039348232 hasConcept C185592680 @default.
• W3039348232 hasConcept C192118531 @default.
• W3039348232 hasConcept C202751555 @default.
• W3039348232 hasConcept C2775905019 @default.
• W3039348232 hasConcept C41183919 @default.
• W3039348232 hasConcept C41685203 @default.
• W3039348232 hasConcept C55493867 @default.
• W3039348232 hasConcept C59593255 @default.
• W3039348232 hasConcept C69366308 @default.
• W3039348232 hasConcept C70721500 @default.
• W3039348232 hasConcept C71240020 @default.
• W3039348232 hasConcept C71924100 @default.
• W3039348232 hasConcept C86803240 @default.
• W3039348232 hasConceptScore W3039348232C104317684 @default.

• next